2012
DOI: 10.1016/j.urology.2012.04.043
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Cancer Control Outcomes in Patients With High-risk Renal Cell Carcinoma Treated With Partial Nephrectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(30 citation statements)
references
References 25 publications
1
27
0
2
Order By: Relevance
“…Moreover, Hansen et al found that partial and radical nephrectomy provided similar cancer-specific survivals among patients with pT3a disease. The 2- and 5- year cancer specific mortalities were 2.1 and 5.1% for partial nephrectomy and 3.0 and 6.0% for radical nephrectomy (p = 0.4) [22]. …”
Section: Discussionmentioning
confidence: 99%
“…Moreover, Hansen et al found that partial and radical nephrectomy provided similar cancer-specific survivals among patients with pT3a disease. The 2- and 5- year cancer specific mortalities were 2.1 and 5.1% for partial nephrectomy and 3.0 and 6.0% for radical nephrectomy (p = 0.4) [22]. …”
Section: Discussionmentioning
confidence: 99%
“…3,17,18 Four observational studies, using data from 1976-2008, have examined the outcomes of PN for high-risk disease. [11][12][13][14] These studies all showed comparable oncologic outcomes for PN and RN. Only two studies examined OS, finding no difference between PN and RN; however, these studies were underpowered.…”
Section: Discussionmentioning
confidence: 69%
“…Several retrospective studies have investigated the comparative effectiveness of PN vs. RN for high-risk disease, but have failed to detect a survival difference in this setting. [11][12][13][14] Despite its flaws, the only level 1 evidence comparing PN and RN demonstrated a survival advantage for RN, calling into question the long-held belief that PN is necessarily better than RN for the elective management of small renal masses. 15,16 We sought to compare survival outcomes between PN and RN for high-risk disease in a large, nationally representative cohort of American patients in the National Cancer Data Base (NCDB).…”
Section: Introductionmentioning
confidence: 99%
“…Ilgą laiką NT buvo pirmo pasirinkimo gydymas, o IR pirmiausia tapo išsigelbėjimu, turint vieną funkcionuojantį inkstą ar esant abipusiams navikams [6]. Vis dėlto pastebėjus, kad IR rezultatai, palyginti su NT, yra panašūs (IR lemia geresnius pooperacinius inkstų funkcijos rezultatus [7][8][9] bei nenusileidžia NT išgyvenamumo ir recidyvavimo rezultatais [10]), IR tapo alternatyviu RCK gydymo metodu [11], o esant mažiems inkstų navikams (MIN), daugelyje medicinos centrų standartiniu operaciniu gydymu [12]. Siekiant išsaugoti inkstų funkciją, IR ypač svarbi sergantiems von Hippel-Lindau liga bei ligomis, kurios sąlygoja lėtinės inkstų ligos progresavimą (hipertenzija, cukrinis diabetas, inksto arterijos stenozė ir lėtinis pielonefritas [11]).…”
Section: įVadasunclassified
“…IR lyginant su NT, lemia geresnę inkstų funkciją po operacijos ir šioms operacijoms būdingi panašūs išgyvenamumo rodikliai [10].…”
Section: Diskusijaunclassified